LMR Partners’s Tango Therapeutics TNGX Stock Holding History

LMR Partners’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.9M	Buy	+347,106	New	+$8.58M	0.04%	389
2024 Q3	–	Sell	-14,000	Closed	-$120K	–	1522
2024 Q2	$120K	Hold	14,000	–	–	﹤0.01%	886
2024 Q1	$111K	Hold	14,000	–	–	﹤0.01%	915
2023 Q4	$139K	Sell	14,000 -11,000	-44%	-$95.5K	﹤0.01%	749
2023 Q3	$282K	Hold	25,000	–	–	﹤0.01%	610
2023 Q2	$83K	Hold	25,000	–	–	﹤0.01%	633
2023 Q1	$98.8K	Hold	25,000	–	–	﹤0.01%	939
2022 Q4	$181K	Buy	25,000 +8,325	+50%	+$58.6K	﹤0.01%	1006
2022 Q3	$60K	Hold	16,675	–	–	﹤0.01%	1082
2022 Q2	$76K	Sell	16,675 -8,325	-33%	-$50.4K	﹤0.01%	1119
2022 Q1	$190K	Sell	25,000 -13,459	-35%	-$117K	﹤0.01%	1149
2021 Q4	$421K	Buy	+38,459	New	+$463K	﹤0.01%	947

Other funds holding TNGX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

LMR Partners's TNGX Position: Q2 2026 in Review

LMR Partners opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 347,106 shares worth $10.9M. The stake represents 0.04% of the portfolio and ranks #389 among its holdings. This is a return to the name: LMR Partners previously reported a position in TNGX as recently as Q2 2024.

LMR Partners first reported a position in TNGX in Q4 2021 and has held it in 12 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

LMR Partners held 347,106 shares of Tango Therapeutics worth $10.9M as of Q2 2026.
Tango Therapeutics was a new LMR Partners position in Q2 2026.
Tango Therapeutics made up 0.04% of LMR Partners's portfolio in Q2 2026, its #389 holding.
LMR Partners first reported a position in Tango Therapeutics in Q4 2021 and has held it in 12 quarters since.
248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.